Literature DB >> 11369807

Fate of intravenously administered squalene and plant sterols in human subjects.

H Relas1, H Gylling, T A Miettinen.   

Abstract

We have studied metabolism of plant sterols and squalene administered intravenously in the form of lipid emulsion mimicking chylomicrons (CM). The CM-like lipid emulsion was prepared by dissolving squalene in commercially available Intralipid. The emulsion was given as an intravenous bolus injection of 30 ml containing 6.3 mg of cholesterol, 1.9 mg of campesterol, 5.7 mg of sitosterol, 1.6 mg of stigmasterol, 18.1 mg of squalene, and 6 g of triglycerides in six healthy volunteers. Blood samples were drawn from the opposite arm before and serially 2.5 -180 min after the injections. The decay of CM squalene, plant sterols, and triglycerides was monoexponential. The half-life of CM squalene was 74 +/- 8 min, that of campesterol was 37 +/- 5 min (P < 0.01 from squalene), and those of sitosterol, stigmasterol, and triglycerides were 17 +/- 2, 15 +/- 1, and 17 +/- 2 min, respectively (P < 0.01 from squalene and campesterol). The CM squalene concentration still exceeded the baseline level 180 min after injection (P = 0.02), whereas plant sterols and triglycerides returned to the baseline level between 45 and 120 min after injection. The half-lives of squalene and campesterol were positively correlated with their fasting CM concentrations. In addition, VLDL squalene, campesterol, and triglyceride concentrations, VLDL, LDL, and HDL sitosterol concentrations, as well as VLDL and LDL stigmasterol concentrations were increased significantly. Cholesterol concentrations increased in VLDL (P < 0.05), but were unchanged in CM after injection. These data suggest that squalene clearance occurs more slowly than that of plant sterols and triglycerides from CM, and that squalene is more tightly associated with triglyceride-rich lipoproteins than are plant sterols in injected CM-like emulsions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369807

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study.

Authors:  Mahmoud Ebrahimi; Nafiseh Farhadian; Ali Reza Amiri; Fatemeh Hataminia; Sara Saffar Soflaei; Mohammad Karimi
Journal:  J Med Virol       Date:  2021-08-26       Impact factor: 20.693

2.  Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells.

Authors:  Carlos Fernández; Yajaira Suárez; Antonio J Ferruelo; Diego Gómez-Coronado; Miguel A Lasunción
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.

Authors:  Bikul Das; Roula Antoon; Rika Tsuchida; Shamim Lotfi; Olena Morozova; Walid Farhat; David Malkin; Gideon Koren; Herman Yeger; Sylvain Baruchel
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

4.  A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines.

Authors:  Million A Tegenge; Robert J Mitkus
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-08-04       Impact factor: 2.745

5.  Plasma plant sterols serve as poor markers of cholesterol absorption in man.

Authors:  Lily Jakulj; Hussein Mohammed; Theo H van Dijk; Theo Boer; Scott Turner; Albert K Groen; Maud N Vissers; Erik S G Stroes
Journal:  J Lipid Res       Date:  2012-11-25       Impact factor: 5.922

Review 6.  Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.

Authors:  Muhammad Shahdaat Bin Sayeed; Selim Muhammad Rezaul Karim; Tasnuva Sharmin; Mohammed Monzur Morshed
Journal:  Medicines (Basel)       Date:  2016-11-15

7.  Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.

Authors:  Christopher B Fox; Lucien Barnes V; Tara Evers; James D Chesko; Thomas S Vedvick; Rhea N Coler; Steven G Reed; Susan L Baldwin
Journal:  Influenza Other Respir Viruses       Date:  2012-11-05       Impact factor: 4.380

Review 8.  Squalene emulsions for parenteral vaccine and drug delivery.

Authors:  Christopher B Fox
Journal:  Molecules       Date:  2009-09-01       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.